Trump determined to link life-saving shots to autism, despite science and political risk.
  • Random Dent@lemmy.mlEnglish
    17·
    1 month ago

    Kimberly-Clark apparently.

    In November 2025, Kimberly-Clark announced it would buy Tylenol producer Kenvue for $48.7 billion. The deal would add the Aveeno, Band-Aid, Benadryl, Benylin, Calpol, Carefree, Clean & Clear, Combantrin, Imodium, Listerine, Motrin, Mylanta, Neutrogena, Nicorette, Johnson’s Baby, Sudafed, Visine, and Zyrtec brands to the company’s portfolio.

    But also…

    Kimberly-Clark shares are mainly held by institutional investors (The Vanguard Group, BlackRock, State Street Corporation, and others).

    So make of that what you will.

    • green_goglin@thelemmy.club
      4·
      1 month ago

      Vanguard runs VOO and StateStreet runs SPY which are S&P500 ETF / Index Funds. That is why they have equity ownership in Kimberly-Clark.

    • obviouspornalt@fedinsfw.appEnglish
      3·
      1 month ago

      In November 2025, Kimberly-Clark announced it would buy Tylenol producer Kenvue for $48.7 billion. The deal would add the Aveeno, Band-Aid, Benadryl, Benylin, Calpol, Carefree, Clean & Clear, Combantrin, Imodium, Listerine, Motrin, Mylanta, Neutrogena, Nicorette, Johnson’s Baby, Sudafed, Visine, and Zyrtec brands to the company’s portfolio.[34][35]